Page 5 - Collection Kit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Need for Comprehensive Diagnostics Remains as Cases Spike Once More FinancialBuzz.com News Commentary Share this article Share this article NEW YORK, April 20, 2021 /PRNewswire/ -- The Director of the U.S. National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, and many other experts have warned that rapid reopening and lifting of pandemic restrictions in many states, as well as the proliferation of more contagious variants, will likely result in ongoing and increased spread of the virus in hot spots around the country. The pandemic remains a very real threat as the num...

Regulatory News: Eurofins (Paris:ERF): empowerDX, a Eurofins subsidiary, announced the launch of its direct-to-consumer, FDA-emergency use authorised, COVID-19 Home Collection Kit on Amazon.

Eurofins Scientific: Eurofins Launches empowerDX COVID-19 Home Collection Kit on Amazon empowerDX, a Eurofins (Paris:ERF) subsidiary, announced the launch of its direct-to-consumer, FDA-emergency use authorised, COVID-19 Home Collection Kit on Amazon. The kits are available to consumers and businesses for purchase without a prescription, enabling greater access to COVID-19 tests, to help the fight against the pandemic. The empowerDX at-home COVID-19 test can detect the virus in both symptomatic and asymptomatic patients. Eurofins Viracor, an infectious disease testing laboratory for m...

Share this article (PRNewsfoto/empowerDX) FRAMINGHAM, Mass., March 10, 2021 /PRNewswire/ -- empowerDX, part of the Eurofins Clinical Diagnostics network, announced the launch of its direct-to-consumer, FDA-emergency use authorized, COVID-19 Home Collection Kit on Amazon. The kits are available to consumers and businesses for purchase without a prescription, enabling greater access to COVID tests, to help the fight against the pandemic. The empowerDX at-home COVID-19 test can detect the virus in both symptomatic and asymptomatic patients.  Eurofins Viracor, an infectious disease testing lab...

FDA Grants Emergency Use Authorization for Home Collection Kit for Advanta Dx SARS-CoV-2 RT-PCR Assay March 01, 2021 08:30 ET | Source: Fluidigm Corporation Fluidigm Corporation Collaboration Agreement to Market Online AZOVA Digital Health Platform Provides Patient Questionnaire, Process for Prescription, Kit Purchase, Sample Collection, and Secure Delivery of Test Results SOUTH SAN FRANCISCO, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensiv...